metastatic High Tumor Mutation Burden Solid Tumors
DBCOND0144327Neoplasms
metastatic High Tumor Mutation Burden Solid Tumors is the indication for 1 drug in DrugBank. It is covered by 2 curated, structured indications.
- Classified under
- Indicated drugs
What you can answer from here — as of October 23, 2026
1Indicated drugWith each drug's targets and mechanismListed above
2Structured indicationsPopulation, line of therapy, route and combination as fields, not proseSign in
Which approved drugs for metastatic High Tumor Mutation Burden Solid Tumors share a target, and which companies have late-stage candidates against it?
Create a free account or log in to explore the full data card.
Create Account